Cargando…
Using the 6-min walk test to assess the clinical response to mepolizumab and conventional therapy in severe eosinophilic asthma
BACKGROUND: Severe asthma limits exercise to avoid respiratory symptoms. The objective of the present study was to investigate the role of the 6-min walk test (6MWT) in severe asthma. METHODS: Consecutive patients with severe eosinophilic asthma were enrolled. A 6MWT was performed before and after 1...
Autores principales: | Lombardi, Carlo, Berti, Alvise, Cottini, Marcello, Roca, Elena, Ventura, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588793/ https://www.ncbi.nlm.nih.gov/pubmed/37868145 http://dx.doi.org/10.1183/23120541.00114-2023 |
Ejemplares similares
-
The emerging roles of eosinophils: Implications for the targeted treatment of eosinophilic-associated inflammatory conditions
por: Lombardi, Carlo, et al.
Publicado: (2022) -
Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma
por: Lombardi, Carlo, et al.
Publicado: (2022) -
Clinical usefulness of mepolizumab in severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016) -
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life()
por: Bagnasco, Diego, et al.
Publicado: (2021) -
Asthma and COVID-19: a dangerous liaison?
por: Lombardi, Carlo, et al.
Publicado: (2021)